Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024424 · ClinicalTrials.gov registry record · NA
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03024424 is a NA study that has completed, run by University of Utah. The registered enrollment target is 16 participants.
The verdict
NCT03024424, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degeneration (AMD), and to assess the impact of presymptomatic genetic testing for choroidal neovascularization (CNV).
Interventions
- BEHAVIORAL Early disclosure
- BEHAVIORAL Late disclosure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03024424
The ClinicalTrials.gov registry entry for NCT03024424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Early disclosure is the first listed.
NCT03024424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03024424 about?
NCT03024424 is a clinical study titled "Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD". The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degenerat...
What is the current status of trial NCT03024424?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-03. Estimated completion is 2017-08-10.
What interventions are being tested in trial NCT03024424?
The interventions under investigation include: Early disclosure (BEHAVIORAL), Late disclosure (BEHAVIORAL).
Who is sponsoring clinical trial NCT03024424?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.